Our continuing vision for the Molecular Imaging Program at Stanford (MIPS) has been to bring molecular imaging technolo-gies to basic science cancer researchers – to create an environ-ment in which non-invasive imaging technologies that permit longitudinal studies of tumor initiation, progression, metastasis and response to therapy would be adopted by basic scientists studying cancer. Within the MIPS program, we continue to develop animal models of cancer in which molecular imag-ing adds new dimensions to experimental design and allows investigators to acquire time-dependent data that could not be obtained in any other way. The MIPS program is supported by numerous funding sources, including the National Institutes of Health, multiple foundations, and strong industry partnerships. Since the inception of MIPS (2003), we have followed a clearly defined roadmap toward translating our work into clinical use to benefit patients.

News & Events

Recent News

Drs. Daldrup-Link and Rao Elected to AIMBE College of Fellows

April 9, 2018

MIPS Research Featured as the Inside Front Cover in the Chemical Science

March 25, 2018

Dr. Raag Airan Received ASCI's 2018 Young Physician-Scientist Award

March 19, 2018

Research Suggests Molecular Imaging Strategy for Determining Molecular Classifications of NSCLC

March 8, 2018

Toward Achieving Precision Health

February 28, 2018

Cancer ‘vaccine’ eliminates tumors in mice

January 31, 2018